Sebahattin Yurdakul
Istanbul Üniversitesi
H-index: 63
Asia-Turkey
Top articles of Sebahattin Yurdakul
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Frequency of AA amyloidosis has decreased in Behçet’s syndrome: a retrospective study with long-term follow-up and a systematic review: Amyloidosis in Behçet’s syndrome | Guzin Karatemiz Sinem Nihal Esatoglu Mert Gurcan Yesim Ozguler Sebahattin Yurdakul | 2023/1/1 | |
Infliximab for vascular involvement in Behçet's syndrome | Clinical Immunology | Gulen Hatemi Nur Beyza Tukek Sinem Nihal Esatoglu Yesim Ozguler Sitki Safa Taflan | 2023/8/1 |
AB1305 A SYSTEMATIC REVIEW OF AA AMYLOIDOSIS AMONG PATIENTS WITH BEHÇET’S SYNDROME | G Karatemiz SN Esatoglu M Gurcan Y Ozguler S Yurdakul | 2022/6/1 | |
AB1308 MYCOPHENOLATE FOR THE TREATMENT OF EYE INVOLVEMENT IN PATIENTS WITH BEHÇET’S SYNDROME | D Ucar Y Ozyazgan SN Esatoglu E Cerme V Hamuryudan | 2022/6/1 | |
Behçet sendromunun vasküler tutulumunda infliksimab tedavisi sonuçları: Retrospektif bir kohort çalışması. | Journal of Turkish Society for Rheumatology | Gülen Hatemi Nur Beyza Tükek Sinem Nihal Esatoğlu Yeşim Özgüler Sıtkı Safa Taflan | 2022/10/2 |
Core set of domains for outcome measures in Behçet's syndrome | Arthritis care & research | Gülen Hatemi Alexa Meara Yesim Özgüler Haner Direskeneli Alfred Mahr | 2022/4 |
Emergence of new manifestations during infliximab treatment in Behçet’s syndrome | Rheumatology | Nur Beyza Tukek Sinem Nihal Esatoglu Gulen Hatemi Elif Buse Calıskan Yılmaz Ozyazgan | 2022/9/1 |
Myocardial work indices in living kidney donor population | European Heart Journal-Cardiovascular Imaging | C Akdeniz S Yurdakul O Cetinarslan IP Canbolat Z Ucar | 2022/2/1 |
Screening for latent tuberculosis before starting TNF-alpha inhibitors in a population with high BCG vaccination rates | Rheumatology International | Aysa Hacioglu Sermin Borekci Melike Melikoglu Yesim Ozguler Sinem Nihal Esatoglu | 2022/8 |
POS0816 DRUG SURVIVAL OF INFLIXIMAB IN BEHÇET’S SYNDROME PATIENTS WITH DIFFERENT TYPES OF INVOLVEMENT | SN Esatoglu B Tukek SS Taflan Y Ozyazgan D Ucar | 2022/6/1 | |
POS0814 DRUG RETENTION RATE, REASONS FOR DISCONTINUATION AND OUTCOME OF INFLIXIMAB USE IN BEHÇET SYNDROME | SN Esatoglu B Tukek SS Taflan Y Ozyazgan D Ucar | 2021/6/1 | |
POS0819 EMERGENCE OF DE NOVO MANIFESTATIONS DURING INFLIXIMAB TREATMENT IN BEHÇET SYNDROME | B Tukek SN Esatoglu G Hatemi EB Caliskan Y Ozyazgan | 2021/6/1 | |
POS1351 CAUSES OF HOSPITALIZATION IN BEHÇET SYNDROME | Y Ozguler G Hatemi AS Pala SN Esatoglu S Ugurlu | 2021/6/1 | |
GIANT THROMBUS IN A STROKE PATIENT WITH BIOLOGICAL MITRAL VALVE REPLACEMENT | M Nalbantoglu S Yurdakul D Necioglu Orken | 2020 | |
P1490 Congenital right coronary artery fistula into right atrium diagnosed with help of multimodality imaging | European Heart Journal-Cardiovascular Imaging | D Erciyes O Ozden Tok S Yurdakul S Bakan O Goktekin | 2020/1/1 |
Locomotor system disease | Sebahattin Yurdakul Pietro Leccese | 2020 | |
Long term follow-up of Behcet’s syndrome patients treated with cyclophosphamide | Rheumatology | Mert Gurcan Sinem Nihal Esatoglu Vedat Hamuryudan Didem Saygin Serdal Ugurlu | 2020/9/1 |
Epidemiology of Behçet syndrome and regional differences in disease expression | Behçet Syndrome | Sebahattin Yurdakul | 2020 |
Behçet's Disease from Rheumatology and Neurology Perspectives with Special Reference to Children | Yaşar B Turgut Ayşe F Tosun Beste K Yüzbaşı Hasan Tunca | 2020/8 | |
SAT0258 DRUG RETENTION RATE AND PROGNOSIS AFTER DISCONTINUATION OF INFLIXIMAB IN PATIENTS WITH BEHÇET SYNDROME | SN Esatoglu B Tukek SS Taflan Y Ozyazgan D Ucar | 2020/6/1 |
